ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,522.30
      1.58%
      US Tech 100
      19,012.80
      3.89%
      Dow Jones
      40,842.79
      0.24%
      Brent Oil
      81.46
      -0.06%
      Bitcoin
      64,325.10
      -0.42%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Avadel Pharmaceuticals PLC (AVDL)

      7. Avadel Pharmaceuticals PLC (AVDL) Financials

      Avadel Pharmaceuticals PLC

      Avadel Pharmaceuticals PLC (AVDL)

      NASDAQ
      16.34
      0.10
      (0.62%)
      Closed July 31 4:00PM
      Delayed by 15 minutes
      16.41
      0.07
      (0.43%)
      After Hours: 5:40PM
      Delayed by 15 minutes

      Avadel Pharmaceuticals PLC Financial Summary

      The current AVDL market cap is 1.58B. The company's latest EPS is USD and P/E is N/A.

      Income Statement

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 007.01M19.45M27.18M
      Operating Income -23.04M-28.3M-35.11M-135.3M-26.04M
      Net Income -27.45M-30.78M-36.27M-28.79M-27.34M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 59.22M68.14M53k027.96M
      Operating Income -27.17M5.38M-85.55M-98.56M-137.85M
      Net Income -33.23M7.03M-77.33M-137.46M-160.28M

      Balance Sheet

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 132.79M140.74M203.1M164.7M167.9M
      Total Liabilities 153.93M178.91M92.95M76.96M89.52M
      Total Equity -21.15M-38.17M110.15M87.74M78.38M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 151.44M311.64M247.27M132.79M164.7M
      Total Liabilities 180.64M149.37M169.02M153.93M76.96M
      Total Equity -29.2M162.27M78.24M-21.15M87.74M

      Cash Flow

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -70.3M-30.23M-100.48M-128.51M-29.7M
      Investing 79.7M5.07M-78.02M-50.09M21.39M
      Financing 14.54M34.44M156.45M135.34M13.19M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -38.33M-48.73M-77.31M-70.3M-128.51M
      Investing 38.72M-69.72M56.93M79.7M-50.09M
      Financing -27k179.68M263k14.54M135.34M

      Stats and Ratios

      Market Cap 1.58B
      Price to Earnings Ratio N/A
      Price to Sales Ratio 0
      Price to Cash Ratio 0
      Price to Book Ratio 0
      Dividend Yield -

      Share Statistics

      Shares Outstanding 96.12M
      Average Volume (1 week) 901.74k
      Average Volume (1 Month) 876.06k
      52 Week Change 18.57%
      52 Week High 19.09
      52 Week Low 9.50
      Spread (Intraday) 0.96 (5.64%)

      Company Info

      Company Name Avadel Pharmaceuticals PLC
      Address 10 earlsfort terrace
      dublin D02 T380
      Website https://www.avadel.com
      Industry pharmaceutical preparations (2834)